TY - JOUR
T1 - The impact of telemedicine on cancer care
T2 - real-world experience from a Peruvian institute during the COVID-19 pandemic
AU - Roque, Katia
AU - Ruiz, Rossana
AU - Otoya-Fernandez, Iris
AU - Galarreta, José
AU - Vidaurre, Tatiana
AU - de Mello, Ramon Andrade
AU - Neciosup, Silvia
AU - Mas, Luis
AU - Gómez, Henry
N1 - Publisher Copyright:
© 2022 Future Medicine Ltd.
PY - 2022/10/1
Y1 - 2022/10/1
N2 - Background: The COVID-19 pandemic caused discontinuities in cancer care (CC) in most countries. Here, the authors describe the real-world impacts of implementing a contingency plan employing telemedicine for CC. Methods: A retrospective study of patients who received CC through telemedicine at the Instituto Nacional de Enfermedades Neoplasicas, Peru, from March 2020 to February 2021 was conducted. Impacts were measured by comparing the amount of CC administered during the pandemic versus the prior year. Results: A total of 16,456 telemedicine visits were carried out. An annual comparative analysis showed a gap of 23% and telemedicine accounted for 27.6% of the total CC administered during the pandemic. A high (4.50/5) level of patient satisfaction with telemedicine was reported. Conclusion: Telemedicine is an important tool to facilitate the continuity of CC.
AB - Background: The COVID-19 pandemic caused discontinuities in cancer care (CC) in most countries. Here, the authors describe the real-world impacts of implementing a contingency plan employing telemedicine for CC. Methods: A retrospective study of patients who received CC through telemedicine at the Instituto Nacional de Enfermedades Neoplasicas, Peru, from March 2020 to February 2021 was conducted. Impacts were measured by comparing the amount of CC administered during the pandemic versus the prior year. Results: A total of 16,456 telemedicine visits were carried out. An annual comparative analysis showed a gap of 23% and telemedicine accounted for 27.6% of the total CC administered during the pandemic. A high (4.50/5) level of patient satisfaction with telemedicine was reported. Conclusion: Telemedicine is an important tool to facilitate the continuity of CC.
KW - cancer care
KW - impact and COVID-19
KW - telemedicine
UR - http://www.scopus.com/inward/record.url?scp=85144584715&partnerID=8YFLogxK
U2 - 10.2217/fon-2022-0239
DO - 10.2217/fon-2022-0239
M3 - Artículo
C2 - 36367446
AN - SCOPUS:85144584715
SN - 1479-6694
VL - 18
SP - 3501
EP - 3508
JO - Future oncology (London, England)
JF - Future oncology (London, England)
IS - 31
ER -
